The aim of this study was to investigate remission and biologic-free remission after orthopaedic surgery and related clinical factors in non-responder to infliximab for rheumatoid arthritis (RA). We analyzed 74 patients who were treated with 3 mg/kg infliximab and methotrexate and underwent orthopaedic surgery after non-responder to infliximab with disease activity score (DAS) 28 (CRP) of ≥3.2....

background the importance of cross-border healthcare, medical and health tourism plays a significant role in the european health policy and health management. after dentistry, orthopaedic treatments are the leading motivation for seeking care in hungary, as patients with rheumatic and motion diseases are drawn to the thermal spas and well-established orthopaedic centres. this paper aims to gain...

©2005 British Editorial Society of Bone and Joint Surgery doi:10.1302/0301-620X.87B11. 16936 $2.00 J Bone Joint Surg [Br] 2005;87-B:1449-51. Medicine, law and religion are the three traditional learned professions. With professionalism should come both privilege and responsibility. As surgeons we study to achieve specialised knowledge and supplement this with training and experience. Our patien...

Robots have been successfully used in commercial industry and have enabled humans to perform tasks which are repetitive, dangerous and requiring extreme force. Their role has evolved and now includes many aspects of surgery to improve safety and precision. Orthopaedic surgery is largely performed on bones which are rigid immobile structures which can easily be performed by robots with great pre...

We describe the development and validation of a scoring system for auditing orthopaedic surgery. It is a minor modification of the POSSUM scoring system widely used in general surgery. The orthopaedic POSSUM system which we have developed gives predictions for mortality and morbidity which correlate well with the observed rates in a sample of 2326 orthopaedic operations over a period of 12 months.

+*McAllister, D (A-American Orthopaedic Society for Sports Medicine (AOSSM) First Time Investigator Award); *Markolf, K; *Oakes, D; *McWilliams, J; *Young, C +*UCLA Medical Center Department of Orthopaedic Surgery, Los Angeles, CA 90095-6902. Department of Orthopaedic Surgery UCLA Center for Health Sciences, Box 956902, Los Angeles, CA 90095-6902, 310-206-5250, Fax: 310-825-1311, DMcAllister@Me...

Ximelagatran represents the first new oral anticoagulant since the introduction of warfarin almost 60 years ago, and has been evaluated for the treatment and prevention of a range of venous and arterial thromboembolic disorders. The MElagatran THRomboprophylaxis in Orthopaedic surgery (METHRO) and EXpanded PRophylaxis Evaluation Surgery Study (EXPRESS) studies have investigated the efficacy and...